-
Cipla partners with ImmunoACT to launch talicabtagene autoleucel, an anti-CD19 CAR-T cell therapy for blood cancers in Africa
22 Jan 2026 22:07 GMT
… , especially for patients with critical healthcare needs. By introducing CAR-T … unmet medical needs across the globe. This strategic partnership with Cipla seeks … treatment.
About Cipla
Established in 1935, Cipla is a global pharmaceutical company focused …
-
Postpartum Depression Drugs Market Size to Surpass USD 1.97 Billion by 2033, Due to Increasing Awareness & Fast Development of Pharmaceuticals – SNS Insider
22 Jan 2026 18:26 GMT
… effective screening methods, sophisticated drug and therapy trials, and … treatment outcomes. Moreover, personalized medicine approaches, such as biomarker-guided … .
Bausch Health Companies Inc.
Cipla Ltd
Novartis AG
Teva Pharmaceutical Industries Ltd …
-
Rewiring Pharma R&D Workflows with Advanced Digital Technologies
22 Jan 2026 13:39 GMT
… Transformation (R&D) at Cipla, which has digitised 100 per … Orchid Pharma, said AI has the potential to dramatically shorten drug development … at Pulse Pharma, observed that the era of synthetic heterocyclic drugs is …
-
Injectable Drugs Market Booming with Rapid Growth Through 2033 | Pfizer Inc., Teva Pharmaceutical Industries Ltd.
22 Jan 2026 12:09 GMT
… Viatris + Mylan N.V
◘ Cipla Inc.
◘ Dr Reddys Laboratories Ltd … , Hematology, etc.)
◘ By Drug Class: Monoclonal Antibodies, Peptides and … Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The segmentation chapter empowers …
-
Pharma sector stocks rally today: Dr. Reddy’s Laboratories up 5%, Granules India jumps 4.33%, Strides Pharma jumps 4%
22 Jan 2026 05:20 GMT
… Mankind Pharma, Marksans Pharma, Panacea Biotech, Piramal Pharma, Sai Life Sciences, Sequent Scientific, Shilpa Medicare … as Sun Pharma (around 1.95-1.98%), Cipla (0.83 … to -1.14%), Max Healthcare Institute, Metropolis Healthcare, and Vijaya Diagnostic. …
-
Antihistamine Drugs Market | Global Forecast 2026-2032 | Revenues to Grow by $1.41 Billion - ResearchAndMarkets.com
21 Jan 2026 17:16 GMT
… ;s offering.
The Antihistamine Drugs Market, experiencing substantial growth, … implications for stakeholders from healthcare professionals to pharmaceutical developers.
Industry Dynamics … Pharma Limited
Bayer AG
Boehringer Ingelheim International GmbH
Cipla …
-
Pharma sector stocks today: Senores up 1.79%, Lupin rises 1%, Sun Pharma jumps 0.81%,
21 Jan 2026 05:31 GMT
… posted positive changes, including:
Senores Pharmaceuticals Ltd.: +2.34% (BSE) … ; -4.46% (NSE)
Onesource Specialty Pharma Ltd.: -3.51% (BSE) … (NSE)
Major Large-Cap Pharma Stocks:
Sun Pharma: 1,625.00 (+0 … : 6,036.25 (+0.44%)
Cipla: 1,381.25 (+0.25% …
-
Cipla to take indigenously made CAR-T cell therapy from ImmunoAct to Africa
20 Jan 2026 18:51 GMT
… HIV /AIDS drugs.
Through subsidiary Medpro Pharmaceutica, Cipla formalised an exclusive license … by Cipla, and given the company’s legacy in providing affordable medicines … profile, leading to reduced ancillary healthcare costs, the note said.
Comments …
-
Sun Pharma Names Sana Shaikh as Head of Marketing
20 Jan 2026 17:41 GMT
… Sun Pharma’s emphasis on strengthening its marketing architecture amid evolving healthcare … and market dynamics.
Before joining Sun Pharma, Shaikh was … at leading pharmaceutical companies such as Nicholas Piramal India Ltd, Cipla and …
-
Advantages, challenges of Indian generic drugs
20 Jan 2026 08:51 GMT
… global pursuit of greater pharmaceutical accessibility, Indian generic drugs have gained popularity … those of patented medicines.
A notable example is Cipla, which reduced the … 1 million pharmacies.
Since 2022, deaths linked to Indian-made medicines have …